All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort. Sogni, P.; Gilbert, C.; Lacombe, K.; Piroth, L.; Rosenthal, E.; Miailhes, P.; Gervais, A.; Esterle, L.; Chas, J.; Poizot-Martin, I.; Dominguez, S.; Simon, A.; Morlat, P.; Neau, D.; Zucman, D.; Bouchaud, O.; Lascoux-Combe, C.; Bani-Sadr, F.; Alric, L.; Goujard, C.; Vittecoq, D.; Billaud, E.; Aumaître, H.; Boué, F.; Valantin, M.A.; Dabis, F.; Salmon, D.; Wittkop, L.. Clin Infect Dis. 2016; 63: p.763–770. doi:doi: 10.1093/cid/ciw379. Epub 2016 Jun 17
Article